Development of Augmented Leukemia/Lymphoma-Specific T-Cell Immunotherapy for Deployment with Haploidentical, Hematompoietic Progenitor- Cell Transplant.

摘要

This is the final progress report for this grant application and describes our progress to date developing T cells with specificity for CD19.